Pay in 4 interest-free payments of $31.99 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
84% - Nasopharyngeal aspirate
These viral antigens are generally detectable in anterior nasal swab specimens during the acute phase of infection
high or waived complexity tests
* Easy to install and use
increasing confidence in results External controls included Facilitates internal laboratory quality control Room temperature storage No refrigerator space needed
GenBody COVID-19 Ag Test coming soon 84% - Nasopharyngeal aspirateFor In Vitro Diagnostic Use. For Prescription Use Only. For Professional Use Only. For Emergency Use Authorization (EUA) Only. The GenBody COVID 19 Ag is an immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS CoV 2 in direct nasopharyngeal (NP) or anterior nasal (AN) swab specimens from individuals who are suspected of COVID 19 by their healthcare provider within the first